Cavinton Forte, tablets 10 mg 90 pcs

Cavinton forte is a drug that improves cerebral circulation. It improves the metabolism of the brain, increasing the consumption of glucose and oxygen by the brain tissue.

Enhances resistance of neurons to hypoxia by increasing glucose transport to the brain through the BBB; switches the process of glucose breakdown to a more energy-saving aerobic route; selectively blocks Ca2+-dependent phosphodiesterase; increases AMP and cGMP levels in the brain.

Enhances ATP concentration and ATP/AMP ratio in brain tissues; increases brain noradrenaline and serotonin metabolism; stimulates the ascending branch of the noradrenergic system, has antioxidant effect.

Reduces platelet aggregation and increased blood viscosity; increases the deformation ability of red blood cells and blocks red blood cell utilization of adenosine; promotes oxygenation of red blood cells. It enhances the neuroprotective effect of adenosine.

It increases cerebral blood flow; it reduces resistance of cerebral blood vessels without significant changes in the indices of systemic circulation (BP, minute volume, HR, RPS). Not only it does not have the effect of “stealing” but also increases blood supply primarily in the ischemic areas of the brain with low perfusion.

Indications

In neurology – acute and chronic cerebrovascular insufficiency (transient ischemia, progressive stroke, conditions after stroke, vascular dementia, atherosclerosis of brain vessels, post-traumatic and hypertensive encephalopathy, vertebrobasilar insufficiency); psychiatric and neurological disorders in patients with cerebrovascular insufficiency (including memory impairment, dizziness, headache, aphasia, apraxia, movement disorders.including memory impairment, dizziness, headache, aphasia, apraxia, movement disorders).

In ophthalmology – vascular eye diseases (atherosclerosis, angiospasm of the choroid and retina, degenerative diseases of the choroid, retina or yellow spot, arterial and venous thrombosis or embolism, secondary glaucoma).

In ENT practice – hearing loss (vascular, toxic or age-related), Meniere’s disease, cochleovestibular neuritis, tinnitus, vertigo (labyrinthine origin); vasovesthetal manifestations of menopausal syndrome.

Active ingredient

Composition

1 tablet contains vinpocetine 10 mg;

excipients:

colloidal silica anhydrous,

magnesium stearate,

How to take, the dosage

The course of treatment and dosage is determined by the doctor.

In most cases, 1 tablet (10 mg) 3 times a day is taken.

Cavinton should be taken after meals.

The course of 1 to 8 months, on average 3 to 4 months. If the drug is withdrawn, the dose of Cavinton is reduced within 2-3 days.

Special Instructions

Cavinton does not have hepato- and nephrotoxic effects, so when prescribing the drug to patients with liver and kidney disease dosage regimen adjustment is not required.

In case of lactose intolerance, note that each tablet contains 83 mg of lactose.

Pediatric use

The drug is not recommended for children under 18 years of age because of the lack of experience in using Cavinton in this patient population.

Contraindications

Pregnancy; lactation; severe forms of heart failure and heart rhythm disturbances;hypersensitivity to vinpocetine or other drug components.

Side effects

Cardiovascular system disorders: aggravation of existing arrhythmias is possible.

Digestive system disorders: nausea, heartburn, dry mouth.

CNS disorders: headache, dizziness, insomnia, weakness.

Allergic reactions: skin rash, urticaria.

Skin reactions: skin hyperemia.

Similarities